Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;3(6):470-80.
doi: 10.1007/s13238-012-2932-6. Epub 2012 Jun 21.

Generation of Calhm1 knockout mouse and characterization of calhm1 gene expression

Affiliations

Generation of Calhm1 knockout mouse and characterization of calhm1 gene expression

Junbing Wu et al. Protein Cell. 2012 Jun.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease among elderly people worldwide. Several genes have been validated to be associated with AD, and calcium homeostasis modulator 1 (Calhm1) is the latest suspected one. To investigate the biological and pathological function of Calhm1 systematically, we generated a Calhm1 conventional knockout mouse. However, both the male and female of elderly Calhm1 knockout (KO) mice showed similar ability to their wild type littermates in spatial learning and memory retrieving. Surprisingly, we found that Calhm1 mRNA could not be detected in mouse brains at different ages, although it is expressed in the human brain tissues. We further found that CpG islands (CGIs) of both mouse and human Calhm1 were hypermethylated, whereas CGI of mouse Calhm2 was hypomethylated. In addition, transcriptional active marker H3K4Di occupied on promoters of human Calhm1 and mouse Calhm2 at a considerable level in brain tissues, while the occupancy of H3K4Di on promoter of mouse Calhm1 was rare. In sum, we found that mouse Calhm1 was of rare abundance in brain tissues. So it might not be suitable to utilize the knockout murine model to explore biological function of Calhm1 in the pathogenesis of AD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer’s disease. Lancet. 2011;377:1019–1031. doi: 10.1016/S0140-6736(10)61349-9. - DOI - PubMed
    1. Beecham G.W., SchnetzBoutaud N., Haines J.L., PericakVance M.A. CALHM1 polymorphism is not associated with late-onset Alzheimer disease. Ann Hum Genet. 2009;73:379–381. doi: 10.1111/j.1469-1809.2009.00509.x. - DOI - PMC - PubMed
    1. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron. 2010;68:270–281. doi: 10.1016/j.neuron.2010.10.013. - DOI - PubMed
    1. Boada M., Antunez C., Lopez-Arrieta J., Galan J.J., Moron F.J., Hernandez I., Marin J., Martinez-Lage P., Alegret M., Carrasco J.M., et al. CALHM1 P86L polymorphism is associated with late-onset Alzheimer’s disease in a recessive model. J Alzheimers Dis. 2010;20:247–251. - PubMed
    1. Brandes J.C., Carraway H., Herman J.G. Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter. Oncogene. 2007;26:6229–6237. doi: 10.1038/sj.onc.1210433. - DOI - PubMed

Publication types